No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4961575 |
chr9:17591830-17591831 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs572577038 |
chr9:17591837-17591838 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs78148565 |
chr9:17591842-17591843 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs138432199 |
chr9:17591854-17591855 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs143820276 |
chr9:17591888-17591889 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs376568598 |
chr9:17591921-17591922 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs184595779 |
chr9:17591923-17591924 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs189209505 |
chr9:17591932-17591933 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs564807442 |
chr9:17591946-17591947 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs116957541 |
chr9:17591978-17591979 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs147252607 |
chr9:17591984-17591985 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs139702656 |
chr9:17591990-17591991 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs542228103 |
chr9:17592001-17592002 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs10963154 |
chr9:17592008-17592009 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs181861437 |
chr9:17592018-17592019 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs548461092 |
chr9:17592036-17592037 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs553084198 |
chr9:17592050-17592051 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs370622368 |
chr9:17592072-17592073 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs538238279 |
chr9:17592082-17592083 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs187670335 |
chr9:17592112-17592113 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs577973384 |
chr9:17592137-17592138 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs539095918 |
chr9:17592146-17592147 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs553980609 |
chr9:17592156-17592157 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs374370875 |
chr9:17592183-17592184 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs74505109 |
chr9:17592187-17592188 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs561243837 |
chr9:17592211-17592212 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs116400424 |
chr9:17592250-17592251 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs149314775 |
chr9:17592260-17592261 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs372953312 |
chr9:17592261-17592262 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs549374312 |
chr9:17592296-17592297 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs189141330 |
chr9:17592400-17592401 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs180952608 |
chr9:17592407-17592408 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs557288514 |
chr9:17592456-17592457 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs186174830 |
chr9:17592464-17592465 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs559191952 |
chr9:17592563-17592564 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs529902593 |
chr9:17592578-17592579 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs575853704 |
chr9:17592632-17592633 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs548448630 |
chr9:17592709-17592710 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs376068756 |
chr9:17592714-17592715 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs537309480 |
chr9:17592727-17592728 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs200019101 |
chr9:17592733-17592734 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs552212051 |
chr9:17592738-17592739 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs571573789 |
chr9:17592793-17592794 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs190202428 |
chr9:17592816-17592817 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs182641960 |
chr9:17592817-17592818 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs185769716 |
chr9:17592878-17592879 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs536427788 |
chr9:17592888-17592889 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs554777067 |
chr9:17592901-17592902 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs530709536 |
chr9:17592905-17592906 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs576243933 |
chr9:17592914-17592915 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|